AC Höper, W Salma, AM Khalid, AD Hafstad… - British Journal of …, 2013 - cambridge.org
The aim of the present study was to investigate the effects of oil extracted from the zooplankton Calanus finmarchicus (Calanus oil) on diet-induced obesity and obesity-related …
Atherosclerosis, the gradual formation of a lipid-rich plaque in the arterial wall is the primary cause of Coronary Artery Disease (CAD), the leading cause of mortality worldwide …
YS Lee, EJ Park, GS Park, SH Ko, J Park… - International Journal of …, 2021 - mdpi.com
Obesity is a major health problem. Compelling evidence supports the beneficial effects of probiotics on obesity. However, the anti-obesity effect of probiotics remains unknown. In this …
K Sachs-Barrable, JW Darlington… - Lipids in Health and …, 2014 - Springer
Background Many drugs are substrates for P-glycoprotein (P-gp) and interactions involving P-gp may be relevant to clinical practice. Co-administration with P-gp inhibitors or inducers …
L Calpe-Berdiel, JC Escola-Gil, N Rotllan… - Metabolism, 2008 - Elsevier
Most studies have focused on the cholesterol-lowering activity of phytosterols; however, other biological actions have also been attributed to these plant compounds. In this study …
J Méndez-González, S Süren-Castillo… - British journal of …, 2010 - cambridge.org
Disodium ascorbyl phytostanol phosphate (FM-VP4) is a synthetic compound derived from sitostanol and campestanol that has proved to be efficient as a cholesterol-lowering therapy …
JR Colca - Expert Opinion on Investigational Drugs, 2009 - Taylor & Francis
This perspective summarizes key compounds from the endocrine and metabolic area that were discontinued during the calendar year 2008. This is a continuation in a series of …
Previous research indicates that animals fed a high fat (HF) diet supplemented with disodium ascorbyl phytostanyl phosphate (DAPP) exhibit reduced mass accumulation when …